| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.1780340408 |
| P698 | PubMed publication ID | 1901492 |
| P2093 | author name string | Graziano F | |
| Robbins M | |||
| Turski P | |||
| Bell CL | |||
| Kornguth S | |||
| Partington C | |||
| P2860 | cites work | MR imaging of systemic lupus erythematosus involving the brain | Q48493240 |
| P433 | issue | 4 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 432-441 | |
| P577 | publication date | 1991-04-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers | |
| P478 | volume | 34 |
| Q47189762 | A Proposed Mechanism for Development of CTE Following Concussive Events: Head Impact, Water Hammer Injury, Neurofilament Release, and Autoimmune Processes |
| Q43786936 | A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus |
| Q72113307 | Abnormalities of magnetic resonance imaging of the central nervous system in patients with systemic lupus erythematosus correlate with disease severity |
| Q70578706 | Assessment of cognitive function in patients with systemic lupus erythematosus |
| Q71775354 | Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus |
| Q36715126 | Asymptomatic brain lesions on cranial magnetic resonance imaging in inflammatory bowel disease |
| Q48276597 | Automated T2 quantitation in neuropsychiatric lupus erythematosus: a marker of active disease. |
| Q35455167 | Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study |
| Q37613091 | Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus |
| Q48491099 | Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies |
| Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
| Q38660157 | Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE) |
| Q74385636 | Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus |
| Q33750289 | Disorders that mimic central nervous system infections |
| Q33217667 | Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice |
| Q31933342 | Evaluation of patients with CNS involvement in SLE. |
| Q72135622 | Focal white-matter lesions in brain of patients with inflammatory bowel disease |
| Q31101744 | Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? |
| Q33564647 | Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum |
| Q31942717 | Internuclear ophthalmoplegia in systemic lupus erythematosus |
| Q48458894 | Interpreting brain scans of lupus patients taken after seizures or migraines |
| Q33358817 | Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series |
| Q71981503 | MRI changes in the central nervous system in a child with lupus erythematosus |
| Q46909297 | Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus |
| Q71598482 | Magnetic resonance imaging of tophaceous gout in the hands and wrists |
| Q40929944 | Nervous system lupus: pathogenesis and rationale for therapy |
| Q33753228 | Neuroimaging in neuropsychiatric systemic lupus erythematosus |
| Q34317758 | Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome. |
| Q33741209 | Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms |
| Q30667365 | Neurologic manifestations of connective tissue disease |
| Q40149699 | Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus |
| Q34250901 | Neuropsychiatric lupus |
| Q36821488 | New insights into central nervous system lupus: a clinical perspective |
| Q36270159 | Pattern of MRI brain in neuro-psychiatric SLE. Effect of anti-phospholipid antibodies: A study at a tertiary care teaching hospital |
| Q31145483 | Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature |
| Q73251573 | Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus |
| Q57331131 | Red ear(s) syndrome associated with child neuropsychiatric systemic lupus erythematosus |
| Q28345781 | Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus |
| Q48663139 | Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment. |
| Q48439095 | Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus |
| Q52020365 | Subdural fluid collections: an unusual manifestation of CNS disease in a connective tissue disorder. |
| Q33195490 | Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance |
| Q74396638 | [Clinical course and response to therapy in a case of transverse myelitis and SLE] |
| Q75310693 | [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations] |
Search more.